Fountain Life Acquires LifeOmic
December 6, 2023
Fountain Life, a preventative health and advanced diagnostics membership company, has acquired LifeOmic, a health data technology firm, obtaining LifeOmic's platform, mobile apps, IP, and engineering team to power Fountain Life's data-driven diagnostics and membership services. The acquisition will integrate LifeOmic's cloud data, genomic analysis, EHR integration, and AI/ML capabilities into Fountain Life's digital and at-home offerings to expand its precision and preventive care services.
- Buyers
- Fountain Life
- Targets
- LifeOmic
- Industry
- Healthcare Services
- Location
- Indiana, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
LifeOmic Acquires Bavard
February 10, 2022
Software
LifeOmic, a precision-health software company based in Indianapolis, has acquired Bavard, a Utah-based conversational AI startup. The acquisition integrates Bavard's enterprise-grade conversational AI and NLP capabilities into LifeOmic's platform to improve customer support, onboarding, and personalized user experiences across its health and wellness products.
-
Quest Diagnostics Acquires LifeLabs from OMERS for CAN$1.35B
July 8, 2024
Healthcare Services
Quest Diagnostics has agreed to acquire LifeLabs from Canadian pension fund OMERS for approximately CAN$1.35 billion (approximately USD $985 million), including net debt. LifeLabs will retain its brand, Toronto-area headquarters, and management, and Quest expects the acquisition to expand its diagnostic footprint in Canada while enhancing service offerings and data security.
-
Insightful Science Acquires Omiq Inc
January 13, 2022
Software
Insightful Science has acquired Omiq Inc to add cloud-based machine learning and high-dimensional flow cytometry analytics to its scientific R&D software portfolio. OMIQ will continue as a standalone product while integrating with Insightful Science’s suite of life-science tools to expand capabilities for biopharma and academic research customers.
-
Lantheus Acquires Life Molecular Imaging from Life Healthcare
July 22, 2025
Healthcare Services
Lantheus Holdings, Inc. completed the acquisition of Life Molecular Imaging Ltd., a subsidiary of Life Healthcare Group Holdings Ltd., gaining the Neuraceq (florbetaben F18) commercial product, expanded Alzheimer’s radiodiagnostic infrastructure, and additional R&D capabilities. As part of the transaction, Dr. Ludger Dinkelborg (formerly CEO of Life Molecular) will join Lantheus as Head of Research & Development, reporting to the CEO.
-
Fortis Life Sciences Acquires International Point of Care
July 12, 2023
Medical Devices
Fortis Life Sciences, LLC has acquired Toronto-based International Point of Care, Inc. (IPOC). The acquisition adds IPOC’s 36,000 sq. ft. GMP and ISO 13485:2016 manufacturing facility and capabilities (lyophilized reagents, membranes, recombinant proteins, and controls) to Fortis’ diagnostics manufacturing platform, enabling end-to-end customizable solutions for immunodiagnostic and molecular diagnostic customers.
-
OmniActive Health Technologies Acquires ENovate Biolife
November 4, 2024
Food & Beverage
OmniActive Health Technologies has acquired ENovate Biolife to expand its portfolio of clinically validated botanical and specialty active ingredients for dietary supplements, functional foods and sports nutrition. The acquisition strengthens OmniActive's R&D, clinical and commercial capabilities and aims to accelerate global distribution of ENovate's ingredients such as Muvz, RedNite and Oxyjun.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.